Case Report: Immune Response Against SARS-CoV-2 Potential Trigger for Adult-Onset Still Disease
Authors of a case study reported severe adult-onset Still disease manifestations in a patient with long-term sequelae of COVID-19.
Authors of a case study reported severe adult-onset Still disease manifestations in a patient with long-term sequelae of COVID-19.
Researchers examined the efficacy and safety of tocilizumab in patients with adult-onset Still’s disease.